Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Endophthalmitis Prophylaxis for Cataract Surgery

Endophthalmitis Prophylaxis for Cataract Surgery Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 REVIEW ARTICLE Aravind Haripriya, MD,* Zervin R. Baam, MS,* and David F. Chang, MD† According to the Endophthalmitis Vitrectomy Study (EVS), Abstract: Endophthalmitis after cataract surgery is a rare but potential‑ most affected individuals lose visual acuity permanently, and vi‑ ly devastating complication. There is great variability in endophthalmitis sual outcomes are often are poor. One third of individuals do not prophylaxis practice patterns worldwide. Treatment varies globally and gain vision better than counting fingers, and 50% do not recover is based on the microbiological profile and availability of formulations. 13 vision better than 20/40. A more recent study reported that 34% Periocular povidone‑iodine antisepsis is universally adopted and consid ‑ of affected patients achieved a final visual acuity of 20/200 or ered the standard of care in most practices. Perioperative topical antibiot‑ 14 worse. With the significant increase in cataract surgery due to ics are also very popular despite the lack of level 1 evidence confirming population aging worldwide, effective endophthalmitis prophy‑ efficacy. Based on growing observational evidence, routine intracameral laxis is a rising global imperative. antibiotic prophylaxis is increasing, especially where approved commer‑ cial intraocular preparations are available. This review http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/endophthalmitis-prophylaxis-for-cataract-surgery-0JEuEHK29E
Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.22608/APO.2017200
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 REVIEW ARTICLE Aravind Haripriya, MD,* Zervin R. Baam, MS,* and David F. Chang, MD† According to the Endophthalmitis Vitrectomy Study (EVS), Abstract: Endophthalmitis after cataract surgery is a rare but potential‑ most affected individuals lose visual acuity permanently, and vi‑ ly devastating complication. There is great variability in endophthalmitis sual outcomes are often are poor. One third of individuals do not prophylaxis practice patterns worldwide. Treatment varies globally and gain vision better than counting fingers, and 50% do not recover is based on the microbiological profile and availability of formulations. 13 vision better than 20/40. A more recent study reported that 34% Periocular povidone‑iodine antisepsis is universally adopted and consid ‑ of affected patients achieved a final visual acuity of 20/200 or ered the standard of care in most practices. Perioperative topical antibiot‑ 14 worse. With the significant increase in cataract surgery due to ics are also very popular despite the lack of level 1 evidence confirming population aging worldwide, effective endophthalmitis prophy‑ efficacy. Based on growing observational evidence, routine intracameral laxis is a rising global imperative. antibiotic prophylaxis is increasing, especially where approved commer‑ cial intraocular preparations are available. This review

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Jul 1, 2017

There are no references for this article.